ENTA vs. CCCC
ENTA (Enanta Pharmaceuticals, Inc.) and CCCC (C4 Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ENTA returned -25.36%/yr vs -38.85%/yr for CCCC. At a 0.33 correlation, their price movements are largely independent.
Performance
ENTA vs. CCCC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENTA achieves a -29.80% return, which is significantly lower than CCCC's 87.96% return.
ENTA
- 1D
- -1.86%
- 1M
- -27.84%
- YTD
- -29.80%
- 6M
- -21.93%
- 1Y
- 48.19%
- 3Y*
- -24.76%
- 5Y*
- -25.36%
- 10Y*
- -7.18%
CCCC
- 1D
- -6.75%
- 1M
- 21.69%
- YTD
- 87.96%
- 6M
- 41.34%
- 1Y
- 107.51%
- 3Y*
- 1.04%
- 5Y*
- -38.85%
- 10Y*
- —
ENTA vs. CCCC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ENTA Enanta Pharmaceuticals, Inc. | -29.80% | 174.26% | -38.89% | -79.77% | -37.79% | 77.62% | -7.29% |
CCCC C4 Therapeutics, Inc. | 87.96% | -46.94% | -36.28% | -4.24% | -81.68% | -2.81% | 29.97% |
Correlation
The correlation between ENTA and CCCC is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Oct 5, 2020 | 0.33 |
The correlation between ENTA and CCCC shifts across timeframes, from 0.20 (1 year) to 0.35 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ENTA:
$319.83M
CCCC:
$452.61M
ENTA:
-$2.67
CCCC:
-$1.18
ENTA:
3.72
CCCC:
11.02
ENTA:
2.77
CCCC:
1.93
ENTA:
$69.21M
CCCC:
$28.71M
ENTA:
$33.44M
CCCC:
$26.90M
ENTA:
-$61.85M
CCCC:
-$107.31M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENTA vs. CCCC — Risk / Return Rank
ENTA
CCCC
ENTA vs. CCCC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enanta Pharmaceuticals, Inc. (ENTA) and C4 Therapeutics, Inc. (CCCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ENTA | CCCC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.62 | ||
| Sortino ratioReturn per unit of downside risk | -0.34 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.24 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 1.41 | 2.08 | -0.66 |
| Martin ratioReturn relative to average drawdown | 2.72 | 4.02 | -1.30 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ENTA | CCCC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.44 | 1.07 | -0.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | -0.33 | -0.02 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.12 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.05 | -0.26 | +0.20 |
Drawdowns
ENTA vs. CCCC - Drawdown Comparison
The maximum ENTA drawdown since its inception was -96.63%, roughly equal to the maximum CCCC drawdown of -97.82%. Use the drawdown chart below to compare losses from any high point for ENTA and CCCC.
Loading charts...
Drawdown Indicators
| ENTA | CCCC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.63% | -97.82% | +1.19% |
Max Drawdown (1Y)Largest decline over 1 year | -34.30% | -52.10% | +17.80% |
Max Drawdown (3Y)Largest decline over 3 years | -83.61% | -90.00% | +6.39% |
Max Drawdown (5Y)Largest decline over 5 years | -95.62% | -97.82% | +2.20% |
Max Drawdown (10Y)Largest decline over 10 years | -96.63% | — | — |
Current DrawdownCurrent decline from peak | -91.24% | -92.89% | +1.65% |
Average DrawdownAverage peak-to-trough decline | -49.23% | -71.93% | +22.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.76% | 26.91% | -9.15% |
Volatility
ENTA vs. CCCC - Volatility Comparison
The current volatility for Enanta Pharmaceuticals, Inc. (ENTA) is 13.36%, while C4 Therapeutics, Inc. (CCCC) has a volatility of 33.23%. This indicates that ENTA experiences smaller price fluctuations and is considered to be less risky than CCCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENTA | CCCC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.36% | 33.23% | -19.87% |
Volatility (6M)Calculated over the trailing 6-month period | 35.53% | 64.03% | -28.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 109.93% | 101.70% | +8.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.36% | 117.54% | -44.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.70% | 113.15% | -52.45% |
Dividends
ENTA vs. CCCC - Dividend Comparison
Neither ENTA nor CCCC has paid dividends to shareholders.
Financials
ENTA vs. CCCC - Financials Comparison
This section allows you to compare key financial metrics between Enanta Pharmaceuticals, Inc. and C4 Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ENTA and CCCC have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CCCC has higher volatility (33.23%) compared to ENTA (13.36%). In terms of maximum drawdown, ENTA dropped -96.63% vs CCCC's -97.82%.
CCCC currently has the higher Sharpe Ratio (1.07 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENTA and CCCC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer